Pages

▼
Monday, December 26, 2022

Youtube Video Describing How JDRF Makes Funding Decisions

›
If you care about research aimed at curing type-1 diabetes, then you should care about JDRF's research funding.  Year after year, they f...
Thursday, December 15, 2022

ADSCC Starts Phase-I Clinical Trial of Extracorporeal Photopheresis (Opera)

›
This is a phase-I, 10 person trial which started in September 2022, and is expected to finish in January 2024.  This trial is for adults (18...
Saturday, December 3, 2022

The FDA Approves Teplizumab Under The Name TZIELD™ (teplizumab-mzwv)

›
On 17-Nov-2022, The USA FDA approved Teplizumab.  This is the first drug ever approved in the United States which changes the course of Type...
Wednesday, November 16, 2022

Results from MultiPepT1De (Multi Peptide Vaccine) by Powrie at King’s College London

›
This is the most recent result from a long line of research led by Colin Dayan and Mark Peakman, at Cardiff University and King's Colleg...
Sunday, October 16, 2022

JDRF Funding for a Cure 2022

›
In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation) asks us to walk to raise money for a ...
Friday, September 16, 2022

Research Dropped As A Practical Cure

›
Every year I have the sad job of removing some projects from my list of active research aimed at curing T1D.  In the perfect world, I would...
Monday, July 11, 2022

Provention Bio Update

›
Provention Bio is a small biotech company targeting several autoimmune diseases.  It has two drug candidates which target T1D: teplizumab (P...